Broad Institute, Inc. - Jun 21, 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
10%+ Owner
Signature
/s/ Dan Shore, Chief Financial Officer
Stock symbol
VERV
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
4
Date filed
6/23/2021, 06:13 PM
Previous filing
Jun 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Other $0 +388K +91.91% $0.00 810K Jun 21, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Broad Institute, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were issued upon the closing of the Issuer's initial public offering in satisfaction of contractual obligations, based on the initial public offering price of $19.00 per share, without payment of any additional consideration by The Broad Institute, Inc. at the time of issuance.